Carl McKinzie
Directeur/Membre du Conseil chez Sofie Biosciences, Inc.
Profil
Carl W.
McKinzie is currently a Director at SOFIE Co., Sofie Biosciences, Inc., Trethera Corp., and Athos Therapeutics, Inc. Previously, he was the Chief Executive Officer at FirstFed Financial Corp.
(California) from 2010 to 2012.
He was also a Partner at BMC Partners LLP and Riordan & McKinzie.
Postes actifs de Carl McKinzie
| Sociétés | Poste | Début |
|---|---|---|
Sofie Biosciences, Inc.
 Sofie Biosciences, Inc. Medical SpecialtiesHealth Technology Sofie Biosciences, Inc. operates as a diagnostics company that provides molecular imaging probes and devices to help scientists and physicians investigate the biology of disease. It combines the discovery and development of new PET imaging probes with innovative imaging systems and chemistry platforms to provide researchers and physicians with tools to better understand the biology of disease. The company was founded by Owen N. Witte, Michael E. Phelps, Jim Heath, Johannes Czernin, and Caius Radu in 2008 and is headquartered in Culver City, CA. | Directeur/Membre du Conseil | - |
Trethera Corp.
 Trethera Corp. Miscellaneous Commercial ServicesCommercial Services Trethera Corp. operates as a biopharmaceutical firm. The company was founded by Caius Radu, Johannes Czernin, David Nathanson, Owen N. Witte and Michael E. Jung and is headquartered in Sherman Oaks, CA. | Directeur/Membre du Conseil | - |
Athos Therapeutics, Inc.
 Athos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Athos Therapeutics, Inc. is a biotech company based in Torrance, CA. Athos Therapeutics develops small molecule therapeutics for immune-mediated diseases using artificial intelligence-generated innovative chemistry and computational platforms. The private company identifies novel drug targets by integrating clinical and molecular datasets into the biological network of a disease and matches them to its small molecule computational chemistry platform. Ath-63, the company's lead drug compound, is moving into a phase I human clinical trial for patients with inflammatory bowel disease in Q1 2022 at the Cleveland Clinic. Other pipeline programs include drugs for lupus and various types of cancers. The company was founded in 2019 by Michael Jung, Allan J. Pantuck, and Dimitrios Iliopoulos, who has been the CEO since then. | Directeur/Membre du Conseil | - |
SOFIE Co.
 SOFIE Co. Pharmaceuticals: MajorHealth Technology SOFIE Co. provides full service radiopharmaceuticals to the nuclear medicine industry. The company is headquartered in Dulles, VA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Carl McKinzie
| Sociétés | Poste | Fin |
|---|---|---|
FirstFed Financial Corp. (California)
 FirstFed Financial Corp. (California) Savings BanksFinance FirstFed Financial Corp. operates as a bank holding company. The company earlier used to provide banking services through its former subsidiary First Federal Bank of California which is now owned by OneWest Bank FSB. It provides commercial banking services such as deposit accounts, including passbook accounts, money market depost accounts, interest bearing checking accounts and certificates of deposit. The company was founded on February 3, 1987 and is headquartered in Los Angeles, CA. | Directeur Général | 31/12/2012 |
Riordan & McKinzie
 Riordan & McKinzie Miscellaneous Commercial ServicesCommercial Services Part of Morgan, Lewis & Bockius LLP, Riordan & McKinzie is a legal services provider. The company is based in Los Angeles, CA. Riordan & McKinzie was acquired by BMC Partners LLP, part of Morgan, Lewis & Bockius LLP from November 25, 2014 on June 25, 2003. | Corporate Officer/Principal | - |
BMC Partners LLP
 BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services BMC Partners LLP provides litigation, corporate, finance, restructuring, employment and benefits, and intellectual property services in all industries. It also offers consulting and advisory services in government, investment management, and mergers and acquisitions. The company was founded on July 1, 2002 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
FirstFed Financial Corp. (California)
FirstFed Financial Corp. (California) Savings BanksFinance FirstFed Financial Corp. operates as a bank holding company. The company earlier used to provide banking services through its former subsidiary First Federal Bank of California which is now owned by OneWest Bank FSB. It provides commercial banking services such as deposit accounts, including passbook accounts, money market depost accounts, interest bearing checking accounts and certificates of deposit. The company was founded on February 3, 1987 and is headquartered in Los Angeles, CA. | Finance |
BMC Partners LLP
BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services BMC Partners LLP provides litigation, corporate, finance, restructuring, employment and benefits, and intellectual property services in all industries. It also offers consulting and advisory services in government, investment management, and mergers and acquisitions. The company was founded on July 1, 2002 and is headquartered in Boston, MA. | Commercial Services |
Riordan & McKinzie
Riordan & McKinzie Miscellaneous Commercial ServicesCommercial Services Part of Morgan, Lewis & Bockius LLP, Riordan & McKinzie is a legal services provider. The company is based in Los Angeles, CA. Riordan & McKinzie was acquired by BMC Partners LLP, part of Morgan, Lewis & Bockius LLP from November 25, 2014 on June 25, 2003. | Commercial Services |
SOFIE Co.
SOFIE Co. Pharmaceuticals: MajorHealth Technology SOFIE Co. provides full service radiopharmaceuticals to the nuclear medicine industry. The company is headquartered in Dulles, VA. | Health Technology |
Sofie Biosciences, Inc.
Sofie Biosciences, Inc. Medical SpecialtiesHealth Technology Sofie Biosciences, Inc. operates as a diagnostics company that provides molecular imaging probes and devices to help scientists and physicians investigate the biology of disease. It combines the discovery and development of new PET imaging probes with innovative imaging systems and chemistry platforms to provide researchers and physicians with tools to better understand the biology of disease. The company was founded by Owen N. Witte, Michael E. Phelps, Jim Heath, Johannes Czernin, and Caius Radu in 2008 and is headquartered in Culver City, CA. | Health Technology |
Athos Therapeutics, Inc.
Athos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Athos Therapeutics, Inc. is a biotech company based in Torrance, CA. Athos Therapeutics develops small molecule therapeutics for immune-mediated diseases using artificial intelligence-generated innovative chemistry and computational platforms. The private company identifies novel drug targets by integrating clinical and molecular datasets into the biological network of a disease and matches them to its small molecule computational chemistry platform. Ath-63, the company's lead drug compound, is moving into a phase I human clinical trial for patients with inflammatory bowel disease in Q1 2022 at the Cleveland Clinic. Other pipeline programs include drugs for lupus and various types of cancers. The company was founded in 2019 by Michael Jung, Allan J. Pantuck, and Dimitrios Iliopoulos, who has been the CEO since then. | Health Technology |
Trethera Corp.
Trethera Corp. Miscellaneous Commercial ServicesCommercial Services Trethera Corp. operates as a biopharmaceutical firm. The company was founded by Caius Radu, Johannes Czernin, David Nathanson, Owen N. Witte and Michael E. Jung and is headquartered in Sherman Oaks, CA. | Commercial Services |
